Table 2. Laboratory findings when patients first visited the outpatient department.
Parameter | Case 1 | Case 2 | Case 3 |
---|---|---|---|
Blood-RT | |||
LY% | – | 14.9 | 37.6 |
MONO% | – | 7.6 | 5.4 |
NEUT% | – | 76.3 | 47.1 |
EOS% | – | 0.8 | 8.5 |
BASO% | – | 0.4 | 1.4 |
Urine-RT | – | GLU 5.5 mmol/L | Normal |
Stool-RT | – | Normal | Normal |
TT, ng/mL | 2.78 | 5.63 | 3.31 |
E2, pg/mL | – | 24 | 20 |
PRL, ng/mL | 7.72 | 8.59 | 11.9 |
LH, IU/L | 5.57 | 5.53 | 3.36 |
FSH, IU/L | 5.47 | 5.48 | 3.45 |
Sperm parameters | |||
pH | – | 7.2 | 7.0 |
Concentration (×106) | – | 15.12 | 204.07 |
Motility | |||
A (%) | – | 4.25 | 10.06 |
A + B (%) | – | 28.78 | 38.68 |
A + B + C (%) | – | 29.25 | 47.80 |
Volume, mL | – | 5.5 | 1.6 |
T-PSA, ng/mL | – | 1.980 | 0.462 |
3-MN, nmol/L | – | 0.15 | – |
3-MT, nmol/L | – | 0.012 | – |
3-NMN, nmol/L | – | 0.45 | – |
–, missing data. RT, routine test; LY, lymphocyte; MONO, monocyte; NEUT, neutrophil; EOS, eosinophil; BASO, basophilicgranulocyte; TT, total testosterone; E2, estradiol; LH, luteinizing hormone; PRL, prolactin; FSH, follicle-stimulating hormone; T-PSA, total prostate specific antigen; 3-MN, 3-metanephrine; 3-MT, 3-methoxytyramine; 3-NMN, 3-normetanephrine.